Latest News & Features
Refine Search
Americas
Federal oversight, funding cuts, and patent uncertainties are forcing universities, startups, and pharma companies to reassess partnership models, finds Marisa Woutersen. 9 September 2025
Careers
Wales’ first MP of ethnic minority background brings tech knowledge and expertise to the IP office, which is carrying out two pivotal consultations. 9 September 2025
Careers
The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas. 8 September 2025
Careers
Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”. 8 September 2025
Americas
The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech. 5 September 2025
Americas
The Finnish wearable tech brand is fighting hard to fend off younger rivals, with the battleground getting bloody. Sarah Speight reports. 5 September 2025
Europe
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen. 4 September 2025
Americas
The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims. 4 September 2025
Americas
The company’s decision to sue US customs may result in a “roadmap” to sidestep ITC orders—and patent litigators are watching, finds Marisa Woutersen. 3 September 2025
Europe
Carpmaels & Ransford appoints two litigation partners as the UK firm expands its presence in Germany in response to UPC demand. 3 September 2025